In a filing, Moderna Inc revealed its Director AFEYAN NOUBAR unloaded Company’s shares for reported $1.66 million on May 01 ’24. In the deal valued at $110.92 per share,15,000 shares were sold. As a result of this transaction, AFEYAN NOUBAR now holds 2,026,931 shares worth roughly $247.55 million.
Then, AFEYAN NOUBAR sold 15,000 shares, generating $1,624,836 in total proceeds. Upon selling the shares at $108.32, the Director now owns 2,041,931 shares.
Before that, AFEYAN NOUBAR sold 15,000 shares. Moderna Inc shares valued at $1,550,703 were divested by the Director at a price of $103.38 per share. As a result of the transaction, AFEYAN NOUBAR now holds 2,056,931 shares, worth roughly $251.21 million.
HSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was increased to $86 from $75. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early January from “a Perform” to “an Outperform”. Canaccord Genuity began covering MRNA with “Hold” recommendation on November 29, 2023. HSBC Securities revised its rating on November 03, 2023. It rated MRNA as “a Hold” which previously was an “a Reduce”.
Price Performance Review of MRNA
On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -2.30% to $122.13. Over the last five days, the stock has gained 9.42%. Moderna Inc shares have risen nearly 22.81% since the year began. Nevertheless, the stocks have fallen -9.08% over the past one year. While a 52-week high of $142.79 was reached on 05/02/24, a 52-week low of $62.55 was recorded on 02/13/24. SMA at 50 days reached $105.36, while 200 days put it at $98.43. A total of 3.94 million shares were traded, compared to the trading of 11.97 million shares in the previous session.
Levels Of Support And Resistance For MRNA Stock
The 24-hour chart illustrates a support level at 118.87, which if violated will result in even more drops to 115.61. On the upside, there is a resistance level at 125.27. A further resistance level may holdings at 128.41. The Relative Strength Index (RSI) on the 14-day chart is 67.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 13.65, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.64%. Stochastics %K at 84.51% indicates the stock is a selling.
